Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan

Fig. 3

A map of the vaccine-derived population immunity for type 1 poliovirus estimated by the dynamic immunity model as of June 30, 2016 (left), and the dynamic immunity traces and 95% credible interval for immunity in Khyber with supplementary immunization activity (SIA) calendar from 2003 to 2016 (right). The dashed marks along the horizontal axis show the timing of the SIAs and the color represents the vaccine used in the SIA, where mOPV1 represents monovalent oral polio vaccine (OPV) for serotype 1, bOPV represents bivalent OPV for serotypes 1 and 3, tOPV represents trivalent OPV (serotypes 1-3), and IPV is the inactivated poliovirus vaccine

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us